Skip to main content
Top
Published in: Journal of General Internal Medicine 6/2018

01-06-2018 | Original Research

Development and Validation of Machine Learning Models for Prediction of 1-Year Mortality Utilizing Electronic Medical Record Data Available at the End of Hospitalization in Multicondition Patients: a Proof-of-Concept Study

Authors: Nishant Sahni, MD, MS, Gyorgy Simon, PhD, Rashi Arora, MD

Published in: Journal of General Internal Medicine | Issue 6/2018

Login to get access

Abstract

Background

Predicting death in a cohort of clinically diverse, multicondition hospitalized patients is difficult. Prognostic models that use electronic medical record (EMR) data to determine 1-year death risk can improve end-of-life planning and risk adjustment for research.

Objective

Determine if the final set of demographic, vital sign, and laboratory data from a hospitalization can be used to accurately quantify 1-year mortality risk.

Design

A retrospective study using electronic medical record data linked with the state death registry.

Participants

A total of 59,848 hospitalized patients within a six-hospital network over a 4-year period.

Main Measures

The last set of vital signs, complete blood count, basic and complete metabolic panel, demographic information, and ICD codes. The outcome of interest was death within 1 year.

Key results

Model performance was measured on the validation data set. Random forests (RF) outperformed logisitic regression (LR) models in discriminative ability. An RF model that used the final set of demographic, vitals, and laboratory data from the final 48 h of hospitalization had an AUC of 0.86 (0.85–0.87) for predicting death within a year. Age, blood urea nitrogen, platelet count, hemoglobin, and creatinine were the most important variables in the RF model. Models that used comorbidity variables alone had the lowest AUC. In groups of patients with a high probability of death, RF models underestimated the probability by less than 10%.

Conclusion

The last set of EMR data from a hospitalization can be used to accurately estimate the risk of 1-year mortality within a cohort of multicondition hospitalized patients.
Appendix
Available only for authorised users
Literature
11.
go back to reference Nguyen OK, Makam AN, Clark C, et al. Predicting all-cause 30-day hospital readmissions using electronic health record data over the course of hospitalization: Model derivation, validation and comparison. J Gen Intern Med. 2015;30(0):S231. https://doi.org/10.1002/jhm.2568. Nguyen OK, Makam AN, Clark C, et al. Predicting all-cause 30-day hospital readmissions using electronic health record data over the course of hospitalization: Model derivation, validation and comparison. J Gen Intern Med. 2015;30(0):S231. https://​doi.​org/​10.​1002/​jhm.​2568.
Metadata
Title
Development and Validation of Machine Learning Models for Prediction of 1-Year Mortality Utilizing Electronic Medical Record Data Available at the End of Hospitalization in Multicondition Patients: a Proof-of-Concept Study
Authors
Nishant Sahni, MD, MS
Gyorgy Simon, PhD
Rashi Arora, MD
Publication date
01-06-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 6/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4316-y

Other articles of this Issue 6/2018

Journal of General Internal Medicine 6/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine